查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1674331

東莨菪鹼市場依劑型、通路及地區分類

Scopolamine Market, By Dosage Form (Tablet, Syrup, Injection, Patch, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球東莨菪鹼市場規模估計為 5.162 億美元，預計到 2032 年將達到 7.974 億美元，2025 年至 2032 年的複合年成長率為 6.4%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 5.162億美元
效能資料 從2020年到2024年 預測期 2025年至2032年
預測期：2025-2032年複合年成長率： 6.40% 2032年價值預測 7.974億美元
數字。 2025年東莨菪鹼各地區市場佔有率（%）
東莨菪鹼市場 - IMG1

東莨菪鹼是一種常用於治療暈動病和噁心的藥物化合物。受娛樂性藥物使用量增加以及許多終端行業應用不斷成長等因素的影響，全球東莨菪鹼市場在過去幾年中穩步成長。東莨菪鹼主要從茄科植物中提取，其中曼陀羅或曼陀羅是其主要商業性來源。它作為腦幹和中樞神經系統其他部位的毒蕈鹼乙醯膽鹼受體的競爭性拮抗劑，阻斷影響平衡和運動感知的前庭系統訊號。它有多種劑型——錠劑、貼片和注射劑——可有效控制暈動病、術後噁心嘔吐以及癌症化療相關的噁心等症狀。

市場動態：

海上和空中旅行的增加、止吐藥消費量的增加以及東莨菪鹼貼劑在術後護理中的臨床使用增加可能會推動全球東莨菪鹼市場的成長。然而，過量服用的副作用以及植物來源提取生物鹼的規定可能會阻礙市場成長。正在進行的研究和開發，開發新的草藥配方，專注於聯合治療，並評估新的治療應用，可能為市場相關人員提供機會。原物料價格的波動也會影響市場參與企業的供應和定價策略。

本研究的主要特點

  • 本報告對全球東莨菪鹼市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
  • 它還揭示了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 它根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數，對全球東莨菪鹼市場的主要企業進行了概述。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球東莨菪鹼市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球東莨菪鹼市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管情景
  • 收購與合作場景
  • 資金籌措與投資
  • PEST分析
  • 波特的分析

4. 全球東莨菪鹼市場-冠狀病毒（COVID-19）大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 市場影響

5. 2020 年至 2032 年全球東莨菪鹼市場（以劑型分類）

  • 錠劑
  • 糖漿
  • 注射
  • 修補
  • 其他

6. 全球東莨菪鹼市場（依分銷通路分類），2020 年至 2032 年

  • 醫院藥房
  • 零售藥局
  • 網路藥局

7. 2020 年至 2032 年全球東莨菪鹼市場（按地區）

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章競爭格局

  • 公司簡介
    • Alchem International
    • Integra LifeSciences Holding Corporation
    • Alkaloids Corporation
    • Boehringer Ingelheim
    • Caleb Pharmaceuticals, Inc.
    • Centroflora Group
    • Fine Chemicals Corporation
    • GlaxoSmithKline plc
    • Henan Fusen Pharmaceutical Co., Ltd.
    • Laboratorio RAAM de Sahuayo
    • Mylan NV（part of Viatris）
    • Novartis AG
    • Pfizer Inc.
    • Pharmaceutical Associates, Inc.
    • Phytex Australia
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Global Alkaloids

第9章分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第10章參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1965

Global Scopolamine Market is estimated to be valued at USD 516.2 Mn in 2025 and is expected to reach USD 797.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 516.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.40% 2032 Value Projection: USD 797.4 Mn
Figure. Scopolamine Market Share (%), By Region 2025
Scopolamine Market - IMG1

Scopolamine is a pharmaceutical compound that is commonly used to curb motion sickness and nausea. Global scopolamine market has witnessed steady growth over the past few due to factors such as increasing recreational drug usage and rising application across numerous end-use industries. Scopolamine is predominantly extracted from plants belonging to the Solanaceae family of which Datura stramonium or Jimson weed is the major commercial source. It acts as a competitive antagonist of muscarinic acetylcholine receptors in the brainstem and other parts of the central nervous system to block signals from the vestibular system affecting balance and motion perception. The drug is available in various dosage forms including tablets, patches, and injections to effectively manage symptoms of motion sickness, post-operative nausea & vomiting, and nausea associated with cancer chemotherapy.

Market Dynamics:

Rising sea and air travel, increasing consumption of antiemetic drugs, and growing clinical use of scopolamine patches for postoperative care can drive the global scopolamine market growth. However, adverse effects associated with overdosage and restrictions on plant-derived alkaloids extraction can hamper the market growth. Ongoing R&D to develop new galenic formulations, focus on combination therapies, and evaluation of additional therapeutic applications can offer opportunities for market players. Fluctuating prices of raw materials also impact the supply and pricing strategies adopted by different market participants.

Key Features of the Study:

  • This report provides in-depth analysis of the global scopolamine market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global scopolamine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Pfizer, Baxter, Caleb Pharmaceuticals, Alkaloids of Australia.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global scopolamine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global scopolamine market.

Detailed Segmentation-

  • By Dosage Form:
    • Tablet
    • Syrup
    • Injection
    • Patch
    • Others
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Alchem International
    • Integra LifeSciences Holding Corporation
    • Alkaloids Corporation
    • Boehringer Ingelheim
    • Caleb Pharmaceuticals, Inc.
    • Centroflora Group
    • Fine Chemicals Corporation
    • GlaxoSmithKline plc
    • Henan Fusen Pharmaceutical Co., Ltd.
    • Laboratorio RAAM de Sahuayo
    • Mylan N.V. (part of Viatris)
    • Novartis AG
    • Pfizer Inc.
    • Pharmaceutical Associates, Inc.
    • Phytex Australia
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Global Alkaloids

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Dosage Form
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Scopolamine Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Scopolamine Market, By Dosage Form, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Tablet
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Syrup
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Injection
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Patch
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Scopolamine Market, By Distribution Channel, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Scopolamine Market, By Region, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Alchem International
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Integra LifeSciences Holding Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Alkaloids Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boehringer Ingelheim
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Caleb Pharmaceuticals, Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Centroflora Group
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Fine Chemicals Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Henan Fusen Pharmaceutical Co., Ltd.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Laboratorio RAAM de Sahuayo
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Mylan N.V. (part of Viatris)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novartis AG
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pfizer Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pharmaceutical Associates, Inc.
    • Phytex Australia
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Global Alkaloids

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact